A US case-control study to estimate infant group B streptococcal disease serological thresholds of risk-reduction.
Saved in:
| Title: | A US case-control study to estimate infant group B streptococcal disease serological thresholds of risk-reduction. |
|---|---|
| Authors: | Rhodes JC; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. icq0@cdc.gov., Kahn R; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA., Bolcen S; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Shang N; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Chung Y; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Farley MM; Georgia Emerging Infections Program, Emory University School of Medicine, Atlanta, GA, USA., Britton AN; Georgia Emerging Infections Program, Emory University School of Medicine, Atlanta, GA, USA., Moore AE; Georgia Department of Public Health, Atlanta, GA, USA., Thomas S; Georgia Emerging Infections Program, Emory University School of Medicine, Atlanta, GA, USA., Nadle J; California Emerging Infections Program, Oakland, CA, USA., Amsden LB; Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA., Skarbinski J; Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA., VanWinden KR; The Permanente Medical Group, San Leandro, California, CA, USA., Barnes M; Colorado Department of Public Health and Environment, Denver, CO, USA., Engesser K; New York State Department of Health, Albany, NY, USA., Ferrieri P; University of Minnesota Medical School, Minneapolis, MN, USA., Hansen AP; Yale School of Public Health, Connecticut Emerging Infections Program, New Haven, CT, USA., Harrison LH; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Jeffrey L; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Nyholm JL; University of Minnesota Medical School, Minneapolis, MN, USA., O'Leary ST; Department of Pediatrics, University of Colorado School of Medicine, Denver, CO, USA., Olson-Chen C; University of Rochester Medical Center, Rochester, NY, USA., Rowlands JV; New York State Department of Health, Albany, NY, USA., Seopaul SA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Thomas AR; Oregon Health Authority, Portland, OR, USA., Wrigley HHN; Connecticut Department of Public Health, Hartford, CT, USA., McGee L; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Vishwanathan SA; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Akhter F; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Alston B; Seneca Federal Health, Chantilly, VA, USA., Jia LT; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Li Y; IHRC, Inc, Atlanta, GA, USA., Patel PY; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Rivers J; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Southwell JE; IHRC, Inc, Atlanta, GA, USA., Tran T; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Maniatis P; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. stephanieschrag@outlook.com. |
| Source: | Nature communications [Nat Commun] 2025 Oct 23; Vol. 16 (1), pp. 9381. Date of Electronic Publication: 2025 Oct 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-64324-y |
